Published in Toxicol Sci on May 01, 1999
An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect (2010) 2.16
Heavy metal poisoning and cardiovascular disease. J Toxicol (2011) 1.24
Association between arsenic exposure from a coal-burning power plant and urinary arsenic concentrations in Prievidza District, Slovakia. Environ Health Perspect (2003) 1.14
Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology (2006) 1.08
Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am J Pathol (2006) 0.99
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide. Mediterr J Hematol Infect Dis (2011) 0.95
Nitric oxide and calcium ions in apoptotic esophageal carcinoma cells induced by arsenite. World J Gastroenterol (2002) 0.91
Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic. Toxicol Appl Pharmacol (2007) 0.91
Binational arsenic exposure survey: methodology and estimated arsenic intake from drinking water and urinary arsenic concentrations. Int J Environ Res Public Health (2012) 0.90
The absence of interleukin-6 enhanced arsenite-induced renal injury by promoting autophagy of tubular epithelial cells with aberrant extracellular signal-regulated kinase activation. Am J Pathol (2009) 0.90
Unventilated indoor coal-fired stoves in Guizhou province, China: cellular and genetic damage in villagers exposed to arsenic in food and air. Environ Health Perspect (2007) 0.86
An Overview of Carcinogenic Heavy Metal: Molecular Toxicity Mechanism and Prevention. J Cancer Prev (2015) 0.84
Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction? Toxicol Appl Pharmacol (2006) 0.84
Arsenic abrogates the estrogen-signaling pathway in the rat uterus. Reprod Biol Endocrinol (2010) 0.82
Mechanism of selenium-induced inhibition of arsenic-enhanced UVR carcinogenesis in mice. Environ Health Perspect (2008) 0.78
Breast cancer, dermatofibromas and arsenic. Indian J Dermatol (2009) 0.78
Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways. Toxicol Appl Pharmacol (2008) 0.77
Human GMDS gene fragment hypermethylation in chronic high level of arsenic exposure with and without arsenic induced cancer. Springerplus (2013) 0.77
A Systematic Review and Meta-Regression Analysis of Lung Cancer Risk and Inorganic Arsenic in Drinking Water. Int J Environ Res Public Health (2015) 0.77
Arsenic exposure is associated with DNA hypermethylation of the tumor suppressor gene p16. J Occup Med Toxicol (2014) 0.76
Protective role of metallothionein (I/II) against pathological damage and apoptosis induced by dimethylarsinic acid. World J Gastroenterol (2004) 0.75
Toxicological assessment of toxic element residues in swine kidney and its role in public health risk assessment. Int J Environ Res Public Health (2009) 0.75
Pharmacokinetic and Genomic Effects of Arsenite in Drinking Water on Mouse Lung in a 30-Day Exposure. Dose Response (2015) 0.75
Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect (1999) 3.07
A Pluto-like radius and a high albedo for the dwarf planet Eris from an occultation. Nature (2011) 2.91
Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A (1997) 2.51
Activity of three murein hydrolases during the cell division cycle of Escherichia coli K-12 as measured in toluene-treated cells. J Bacteriol (1976) 2.49
VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization. Eur J Immunol (1986) 2.31
DMSA and DMPS--water soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol (1983) 1.76
Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol (2001) 1.72
Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol (2001) 1.65
Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65
Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol (2002) 1.60
Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults. J Pediatr (1994) 1.58
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect (2000) 1.58
Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci (2001) 1.56
Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol (2001) 1.48
Arsenic risk assessment. Environ Health Perspect (1994) 1.47
Inorganic arsenic: a need and an opportunity to improve risk assessment. Environ Health Perspect (1997) 1.47
Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int (2007) 1.46
Interspecies differences in susceptibility to perturbation of thyroid homeostasis: a case study with perchlorate. Regul Toxicol Pharmacol (2004) 1.45
An in vivo hamster bioassay to assess the toxicity of particulates for the lungs. Toxicol Appl Pharmacol (1982) 1.43
Procedures for health risk assessment in Europe. Regul Toxicol Pharmacol (2001) 1.41
[Carnitine palmitoyltransferase deficiency as the cause of effort rhabdomyolysis]. Med Clin (Barc) (1998) 1.39
Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol Carcinog (2001) 1.35
Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res (2001) 1.33
Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol Sci (2000) 1.30
Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol (1993) 1.29
Choroid plexus protects cerebrospinal fluid against toxic metals. FASEB J (1991) 1.27
Comparative biochemical and tissue distribution study of four distinct CD45 antigen specificities. J Immunol (1988) 1.26
Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol Appl Pharmacol (2001) 1.26
Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem Res Toxicol (1995) 1.26
Rabbit muscle creatine phosphokinase. CDNA cloning, primary structure and detection of human homologues. J Biol Chem (1984) 1.24
Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci (2001) 1.21
Basis for the observed fluctuation of carboxypeptidase II activity during the cell cycle in BUG 6, a temperature-sensitive division mutant of Escherichia coli. J Bacteriol (1977) 1.13
Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res (1997) 1.12
Stimulating research to improve the scientific basis of risk assessment. Toxicol Sci (1999) 1.11
Assessing the relationship between environmental lead concentrations and adult blood lead levels. Risk Anal (1994) 1.11
Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain. J Biol Chem (2001) 1.10
Assessing the contribution from lead in mining wastes to blood lead. Regul Toxicol Pharmacol (1990) 1.10
Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol (1994) 1.10
Neurobehavioral effects from exposure to dental amalgam Hg(o): new distinctions between recent exposure and Hg body burden. FASEB J (1998) 1.10
Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance. Oncogene (2006) 1.09
Novel properties of bacterial elongation factor Tu. Proc Natl Acad Sci U S A (1978) 1.09
Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis (1997) 1.09
N-(2,3-dimercaptopropyl)phthalamidic acid (DMPA) increases polonium-210 excretion. Biol Met (1990) 1.07
Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol Lett (2001) 1.07
Issues in arsenic cancer risk assessment. Environ Health Perspect (1996) 1.05
Cadmium-binding proteins of rat testes. Characterization of a low-molecular-mass protein that lacks identity with metallothionein. Biochem J (1984) 1.04
DNA and gene therapy: uncoating of polyoma pseudovirus in mouse embryo cells. Proc Natl Acad Sci U S A (1970) 1.04
Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chem Res Toxicol (1999) 1.04
A deoxyribonuclease found after infection of Bacillus subtilis with phage SP3. Proc Natl Acad Sci U S A (1965) 1.04
Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions. Cancer Res (2001) 1.04
Cadmium-induced DNA strand damage in cultured liver cells: reduction in cadmium genotoxicity following zinc pretreatment. Toxicol Appl Pharmacol (1992) 1.04
Cancer risk in an arsenic-contaminated area of Chile. Toxicol Ind Health (1997) 1.03
Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic. Toxicol Appl Pharmacol (1996) 1.02
Evidence that nitric oxide enhances cadmium toxicity by displacing the metal from metallothionein. Chem Res Toxicol (1996) 1.02
Is DDT use a public health problem in Mexico? Environ Health Perspect (1996) 1.02
DNA and gene therapy: transfer of mouse DNA to human and mouse embryonic cells by polyoma pseudovirions. Proc Natl Acad Sci U S A (1971) 1.02
The location of the D-alanyl ester in the ribitol teichoic acid of Staphylococcus aureus. Biochem Biophys Res Commun (1970) 1.01
Formation of nucleoprotein complexes between polyoma empty capsides and DNA. J Virol (1975) 1.01
Minimal role of metallothionein in decreased chelator efficacy for cadmium. Toxicol Appl Pharmacol (1983) 0.99
Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions. Arthritis Rheum (2000) 0.99
Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers. J Pharmacol Exp Ther (1994) 0.98
Relative in vitro affinity of hepatic metallothionein for metals. Toxicol Lett (1984) 0.98
Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice. Toxicology (2000) 0.98
Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans. J Pharmacol Exp Ther (1991) 0.97
Studies on the mechanisms of arsenic-induced self tolerance developed in liver epithelial cells through continuous low-level arsenite exposure. Toxicol Sci (2000) 0.97
Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. Toxicology (1995) 0.97
Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem Res Toxicol (2000) 0.97
Central nervous system toxicity of manganese. I. Inhibition of spontaneous motor activity in rats after intrathecal administration of manganese chloride. Fundam Appl Toxicol (1995) 0.96
Structural basis of the antagonism between inorganic mercury and selenium in mammals. Chem Res Toxicol (2000) 0.96
In vitro cadmium-DNA interactions: cooperativity of cadmium binding and competitive antagonism by calcium, magnesium, and zinc. Toxicol Appl Pharmacol (1984) 0.96
The deoxycytidylate deaminase found in Bacillus subtilis infected with phage SP8. Biochemistry (1967) 0.95
Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol Appl Pharmacol (1999) 0.95
Central nervous system toxicity of manganese. II: Cocaine or reserpine inhibit manganese concentration in the rat brain. Neurotoxicology (1999) 0.95
Polymerization of the bacterial elongation factor for protein synthesis, EF-Tu. Eur J Biochem (1979) 0.95
Deoxythymidylate 5'-nucleotidase. Purification and properties of an enzyme found after infection of Bacillus subtilis with phage SP5C. J Biol Chem (1966) 0.94
Chemical mixtures from a public health perspective: the importance of research for informed decision making. Toxicology (1995) 0.94
Nitric oxide induces metallothionein (MT) gene expression apparently by displacing zinc bound to MT. Toxicol Lett (2001) 0.94
Chk1 phosphorylation of Metnase enhances DNA repair but inhibits replication fork restart. Oncogene (2012) 0.94
Possible role of caspase-3 inhibition in cadmium-induced blockage of apoptosis. Toxicol Appl Pharmacol (2000) 0.93
Polyoma pseudovirions. I. Sequence of events in primary mouse embryo cells leading to pseudovirus production. J Virol (1972) 0.93
Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res (1995) 0.93
Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol Appl Pharmacol (2000) 0.92
Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol Appl Pharmacol (1999) 0.92
Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat. J Pharmacol Exp Ther (1993) 0.91
Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology (1994) 0.91
Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation. J Pharmacol Exp Ther (1990) 0.91
Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215). Br J Pharmacol (2006) 0.91
Levels of dichloro-dyphenyl-trichloroethane (DDT) metabolites in maternal milk and their determinant factors. Arch Environ Health (1999) 0.91
Induction of T cell function via the gp33/27 activation inducer molecule (AIM) requires co-expression of the CD3/TcR complex. Eur J Immunol (1989) 0.91
National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res (1993) 0.90
Clinical, histological and molecular reversibility of zidovudine myopathy. J Neurol Sci (1998) 0.89
Genetic background but not metallothionein phenotype dictates sensitivity to cadmium-induced testicular injury in mice. Toxicol Appl Pharmacol (2001) 0.89
Behavioral effects of low-level exposure to Hg0 among dental professionals: a cross-study evaluation of psychomotor effects. Neurotoxicol Teratol (1998) 0.89
Sensitivity to cadmium-induced genotoxicity in rat testicular cells is associated with minimal expression of the metallothionein gene. Toxicol Appl Pharmacol (1995) 0.88
Beneficial effect of indomethacin on acid-induced esophagitis in cats. Dig Dis Sci (1981) 0.88
Fluorometric determination of 2,3-dimercaptopropane-1-sulfonic acid and other dithiols by precolumn derivatization with bromobimane and column liquid chromatography. J Chromatogr (1986) 0.88
The pulmonary toxicity of an ash sample from the MT. St. Helens Volcano. Exp Lung Res (1981) 0.88
Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro. Toxicol Sci (1998) 0.88
Concentration of metallothionein in major organs of rats after administration of various metals. Fundam Appl Toxicol (1985) 0.88
Evaluation of the direct genotoxic potential of cadmium in four different rodent cell lines. Toxicology (1998) 0.87